5 recruiting, 2 completed, 1 active not recruiting. 5 Phase 2, 3 Phase 1, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 4, Completed 1 |
| Phase 1 | 3 | Recruiting 2, Completed 1 |
| Early Phase 1 | 1 | Active not recruiting 1 |
Follow Gallium Ga 68-DOTATATE: new trials by email Literature Review of Gallium Ga 68-DOTATATE trials Research Report on Gallium Ga 68-DOTATATE
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer Biopsy, Biospecimen Collection, Computed Tomography - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 2 | Recruiting | OHSU Knight Cancer Institute | 10 | 2026-06-30 | 2026-06-05 |
| RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma Actinium Ac 225 DOTATATE RYZ101, Biospecimen Collection, Computed Tomography - Recurrent Meningioma | Phase 1 / Phase 2 | Recruiting | Joshua Palmer | 30 | 2025-11-12 | 2026-08-13 |
| Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors. Stereotactic Body Radiation Therapy, Lutetium Lu 177 Dotatate, Computed Tomography - Digestive System Neuroendocrine Tumor, Unresectable Digestive System Neuroendocrine Neoplasm | Phase 1 | Recruiting | Emory University | 15 | 2025-10-14 | 2026-03-02 |
| Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells Biospecimen Collection, Computed Tomography, Gallium Ga 68-DOTATATE - Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic Prostate Neuroendocrine Carcinoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 35 | 2023-12-27 | 2026-11-03 |
| Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy Gallium Ga 68-DOTATATE, Lutetium Lu 177 Dotatate, Magnetic Resonance Imaging - Grade 1 Meningioma, Grade 2 Meningioma | Phase 2 | Recruiting | Mayo Clinic | 42 | 2020-04-14 | 2026-10-13 |
| An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography - Ganglioneuroblastoma, Ganglioneuroma | Early Phase 1 | Active not recruiting | Mayo Clinic | 20 | 2019-09-23 | 2026-03-31 |
| Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography - Meningioma | Phase 1 | Completed | M.D. Anderson Cancer Center | 13 | 2019-01-10 | 2023-09-01 |
| Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer CT (Computed Tomography), Gallium Ga 68-DOTATATE, Positron Emission Tomography - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 2 | Completed | Emory University | 17 | 2018-02-22 | 2025-07-17 |
Meningioma (3) · Prostatic Neoplasms (2) · Breast Neoplasms (1) · Ganglioneuroblastoma (1) · Ganglioneuroma (1) · Gastro-enteropancreatic neuroendocrine tumor (1) · Neuroblastoma (1)
Emory University (2) · Mayo Clinic (2) · Joshua Palmer (1) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · OHSU Knight Cancer Institute (1)
United States (8)
Jason M Johnson (1) · John M Floberg (1) · Joshua D Palmer, MD (1) · Kenneth W. Merrell, MD (1) · Mehmet Asim Bilen, MD (1) · Nadia Laack, MD (1) · Pretesh Patel, MD (1) · Rodney F Pommier (1)
P30CA138292 (1), UM1CA186691 (1)